ImageneBio Inc
General ticker "IMA" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $697.3M (TTM average)
ImageneBio Inc does not follow the US Stock Market performance with the rate: -31.8%.
Estimated limits based on current volatility of 3.5%: low 6.64$, high 7.12$
Factors to consider:
- Earnings expected soon, date: 2026-03-05 bmo
- Total employees count: 67 as of 2021
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [9.54$, 27.52$]
- 2025-12-31 to 2026-12-31 estimated range: [7.73$, 22.94$]
Financial Metrics affecting the IMA estimates:
- Negative: with PPE of -20.7 at the end of fiscal year the price was high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -5.01 <= 0.06
- Negative: negative Net income
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Positive: Inventory ratio change, % of 0 <= 0
- Negative: Industry earnings per price (median), % of -15.95 <= 0
- Negative: Investing cash flow per share per price, % of -3.80 <= -0.64
Short-term IMA quotes
Long-term IMA plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $15.62MM | $9.16MM | $3.50MM |
| Operating Expenses | $86.52MM | $84.58MM | $40.50MM |
| Operating Income | $-70.90MM | $-75.42MM | $-37.00MM |
| Non-Operating Income | $2.14MM | $7.09MM | $0.45MM |
| R&D Expense | $64.32MM | $59.65MM | $32.11MM |
| Income(Loss) | $-68.77MM | $-68.33MM | $-36.55MM |
| Taxes | $0.00MM | $-0.16MM | $0.01MM |
| Profit(Loss)* | $-68.77MM | $-68.17MM | $-49.23MM |
| Stockholders Equity | $146.97MM | $169.76MM | $125.93MM |
| Assets | $172.26MM | $192.09MM | $141.51MM |
| Operating Cash Flow | $-74.11MM | $-79.74MM | $-46.00MM |
| Capital expenditure | $1.43MM | $0.41MM | $0.00MM |
| Investing Cash Flow | $-99.28MM | $64.14MM | $-34.90MM |
| Financing Cash Flow | $1.09MM | $75.98MM | $0.00MM |
| Earnings Per Share** | $-1.90 | $-1.63 | $-1.02 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.